Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7

Detalhes bibliográficos
Autor(a) principal: Silva, Tabata M. [UNESP]
Data de Publicação: 2019
Outros Autores: Moretto, Fernanda C. F. [UNESP], De Sibio, Maria T. [UNESP], Gonçalves, Bianca M. [UNESP], Oliveira, Miriane [UNESP], Olimpio, Regiane M. C. [UNESP], Oliveira, Diego A. M. [UNESP], Costa, Sarah M. B. [UNESP], Deprá, Igor C. [UNESP], Namba, Vickeline [UNESP], Nunes, Maria T., Nogueira, Célia R. [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
DOI: 10.20945/2359-3997000000114
Texto Completo: http://dx.doi.org/10.20945/2359-3997000000114
http://hdl.handle.net/11449/187698
Resumo: Objective: To verify the physiological action of triiodothyronine T3 on the expression of transforming growth factor α (TGFA) mRNA in MCF7 cells by inhibition of RNA Polymerase II and the MAPK/ERK pathway. Materials and methods: The cell line was treated with T3 at a physiological dose (10-9M) for 10 minutes, 1 and 4 hour (h) in the presence or absence of the inhibitors, α-amanitin (RNA polymerase II inhibitor) and PD98059 (MAPK/ERK pathway inhibitor). TGFA mRNA expression was analyzed by RT-PCR. For data analysis, we used ANOVA, complemented with the Tukey test and Student t-test, with a minimum significance of 5%. Results: T3 increases the expression of TGFA mRNA in MCF7 cells in 4 h of treatment. Inhibition of RNA polymerase II modulates the effect of T3 treatment on the expression of TGFA in MCF7 cells. Activation of the MAPK/ERK pathway is not required for T3 to affect the expression of TGFA mRNA. Conclusion: Treatment with a physiological concentration of T3 after RNA polymerase II inhibition altered the expression of TGFA. Inhibition of the MAPK/ERK pathway after T3 treatment does not interfere with the TGFA gene expression in a breast adenocarcinoma cell line.
id UNSP_e3e16967d8bff2e6a4963c8a8a613e69
oai_identifier_str oai:repositorio.unesp.br:11449/187698
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7Breast cancerGene expressionNongenomic actionsThyroid hormoneObjective: To verify the physiological action of triiodothyronine T3 on the expression of transforming growth factor α (TGFA) mRNA in MCF7 cells by inhibition of RNA Polymerase II and the MAPK/ERK pathway. Materials and methods: The cell line was treated with T3 at a physiological dose (10-9M) for 10 minutes, 1 and 4 hour (h) in the presence or absence of the inhibitors, α-amanitin (RNA polymerase II inhibitor) and PD98059 (MAPK/ERK pathway inhibitor). TGFA mRNA expression was analyzed by RT-PCR. For data analysis, we used ANOVA, complemented with the Tukey test and Student t-test, with a minimum significance of 5%. Results: T3 increases the expression of TGFA mRNA in MCF7 cells in 4 h of treatment. Inhibition of RNA polymerase II modulates the effect of T3 treatment on the expression of TGFA in MCF7 cells. Activation of the MAPK/ERK pathway is not required for T3 to affect the expression of TGFA mRNA. Conclusion: Treatment with a physiological concentration of T3 after RNA polymerase II inhibition altered the expression of TGFA. Inhibition of the MAPK/ERK pathway after T3 treatment does not interfere with the TGFA gene expression in a breast adenocarcinoma cell line.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Departamento de Medicina Interna Faculdade de Medicina de Botucatu Universidade Estadual Paulista (UNESP)Universidade Estadual Paulista (UNESP)Departamento de Fisiologia e Biofísica Instituto de Ciencias Biomédicas Universidade de São Paulo (USP)Departamento de Medicina Interna Faculdade de Medicina de Botucatu Universidade Estadual Paulista (UNESP)Universidade Estadual Paulista (UNESP)FAPESP: 2013/05629-4FAPESP: 2014/15209-5FAPESP: 2015/09686-8Universidade Estadual Paulista (Unesp)Universidade de São Paulo (USP)Silva, Tabata M. [UNESP]Moretto, Fernanda C. F. [UNESP]De Sibio, Maria T. [UNESP]Gonçalves, Bianca M. [UNESP]Oliveira, Miriane [UNESP]Olimpio, Regiane M. C. [UNESP]Oliveira, Diego A. M. [UNESP]Costa, Sarah M. B. [UNESP]Deprá, Igor C. [UNESP]Namba, Vickeline [UNESP]Nunes, Maria T.Nogueira, Célia R. [UNESP]2019-10-06T15:44:33Z2019-10-06T15:44:33Z2019-05-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article142-147application/pdfhttp://dx.doi.org/10.20945/2359-3997000000114Archives of Endocrinology and Metabolism, v. 63, n. 2, p. 142-147, 2019.2359-42922359-3997http://hdl.handle.net/11449/18769810.20945/2359-3997000000114S2359-399720190002001422-s2.0-85066163660S2359-39972019000200142.pdfScopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengArchives of Endocrinology and Metabolisminfo:eu-repo/semantics/openAccess2023-11-02T06:11:00Zoai:repositorio.unesp.br:11449/187698Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T16:43:54.224053Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7
title Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7
spellingShingle Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7
Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7
Silva, Tabata M. [UNESP]
Breast cancer
Gene expression
Nongenomic actions
Thyroid hormone
Silva, Tabata M. [UNESP]
Breast cancer
Gene expression
Nongenomic actions
Thyroid hormone
title_short Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7
title_full Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7
title_fullStr Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7
Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7
title_full_unstemmed Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7
Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7
title_sort Triiodothyronine (T3) upregulates the expression of proto-oncogene TGFA independent of MAPK/ERK pathway activation in the human breast adenocarcinoma cell line, MCF7
author Silva, Tabata M. [UNESP]
author_facet Silva, Tabata M. [UNESP]
Silva, Tabata M. [UNESP]
Moretto, Fernanda C. F. [UNESP]
De Sibio, Maria T. [UNESP]
Gonçalves, Bianca M. [UNESP]
Oliveira, Miriane [UNESP]
Olimpio, Regiane M. C. [UNESP]
Oliveira, Diego A. M. [UNESP]
Costa, Sarah M. B. [UNESP]
Deprá, Igor C. [UNESP]
Namba, Vickeline [UNESP]
Nunes, Maria T.
Nogueira, Célia R. [UNESP]
Moretto, Fernanda C. F. [UNESP]
De Sibio, Maria T. [UNESP]
Gonçalves, Bianca M. [UNESP]
Oliveira, Miriane [UNESP]
Olimpio, Regiane M. C. [UNESP]
Oliveira, Diego A. M. [UNESP]
Costa, Sarah M. B. [UNESP]
Deprá, Igor C. [UNESP]
Namba, Vickeline [UNESP]
Nunes, Maria T.
Nogueira, Célia R. [UNESP]
author_role author
author2 Moretto, Fernanda C. F. [UNESP]
De Sibio, Maria T. [UNESP]
Gonçalves, Bianca M. [UNESP]
Oliveira, Miriane [UNESP]
Olimpio, Regiane M. C. [UNESP]
Oliveira, Diego A. M. [UNESP]
Costa, Sarah M. B. [UNESP]
Deprá, Igor C. [UNESP]
Namba, Vickeline [UNESP]
Nunes, Maria T.
Nogueira, Célia R. [UNESP]
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv Silva, Tabata M. [UNESP]
Moretto, Fernanda C. F. [UNESP]
De Sibio, Maria T. [UNESP]
Gonçalves, Bianca M. [UNESP]
Oliveira, Miriane [UNESP]
Olimpio, Regiane M. C. [UNESP]
Oliveira, Diego A. M. [UNESP]
Costa, Sarah M. B. [UNESP]
Deprá, Igor C. [UNESP]
Namba, Vickeline [UNESP]
Nunes, Maria T.
Nogueira, Célia R. [UNESP]
dc.subject.por.fl_str_mv Breast cancer
Gene expression
Nongenomic actions
Thyroid hormone
topic Breast cancer
Gene expression
Nongenomic actions
Thyroid hormone
description Objective: To verify the physiological action of triiodothyronine T3 on the expression of transforming growth factor α (TGFA) mRNA in MCF7 cells by inhibition of RNA Polymerase II and the MAPK/ERK pathway. Materials and methods: The cell line was treated with T3 at a physiological dose (10-9M) for 10 minutes, 1 and 4 hour (h) in the presence or absence of the inhibitors, α-amanitin (RNA polymerase II inhibitor) and PD98059 (MAPK/ERK pathway inhibitor). TGFA mRNA expression was analyzed by RT-PCR. For data analysis, we used ANOVA, complemented with the Tukey test and Student t-test, with a minimum significance of 5%. Results: T3 increases the expression of TGFA mRNA in MCF7 cells in 4 h of treatment. Inhibition of RNA polymerase II modulates the effect of T3 treatment on the expression of TGFA in MCF7 cells. Activation of the MAPK/ERK pathway is not required for T3 to affect the expression of TGFA mRNA. Conclusion: Treatment with a physiological concentration of T3 after RNA polymerase II inhibition altered the expression of TGFA. Inhibition of the MAPK/ERK pathway after T3 treatment does not interfere with the TGFA gene expression in a breast adenocarcinoma cell line.
publishDate 2019
dc.date.none.fl_str_mv 2019-10-06T15:44:33Z
2019-10-06T15:44:33Z
2019-05-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.20945/2359-3997000000114
Archives of Endocrinology and Metabolism, v. 63, n. 2, p. 142-147, 2019.
2359-4292
2359-3997
http://hdl.handle.net/11449/187698
10.20945/2359-3997000000114
S2359-39972019000200142
2-s2.0-85066163660
S2359-39972019000200142.pdf
url http://dx.doi.org/10.20945/2359-3997000000114
http://hdl.handle.net/11449/187698
identifier_str_mv Archives of Endocrinology and Metabolism, v. 63, n. 2, p. 142-147, 2019.
2359-4292
2359-3997
10.20945/2359-3997000000114
S2359-39972019000200142
2-s2.0-85066163660
S2359-39972019000200142.pdf
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Archives of Endocrinology and Metabolism
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 142-147
application/pdf
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1822182385514446848
dc.identifier.doi.none.fl_str_mv 10.20945/2359-3997000000114